QuellTX
Bahire Kalfaoglu has a diverse background in scientific research and development. Bahire is currently employed as a Scientist II at Quell Therapeutics since May 2022. Prior to that, from February 2019 to March 2022, they worked as a Postdoctoral Researcher at Imperial College London. Additionally, they worked as a PhD Student at the same institution from January 2016 to January 2019. In 2014, Bahire worked as a Scientific Researcher at Imperial College London for a period of nine months.
Bahire Kalfaoglu has a Bachelor's Degree (Hons) in Biomedical Sciences, General from Durham University. Bahire also holds a Master of Research degree in Chemistry from Imperial College London. In addition, they have a Doctor of Philosophy (Ph.D.) degree in Clinical Medicine, also from Imperial College London. The specific years of their education are not provided.
This person is not in the org chart
This person is not in any offices
QuellTX
4 followers
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions.Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cellengineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.